Prevention of Cisplatin-Induced Emesis by the Oral Neurokinin-1 Antagonist, MK-869, in Combination With Granisetron and Dexamethasone or With Dexamethasone Alone

Barry J. Gertz(Blackstone (United States)), Sergio Poli(Brigham and Women's Hospital), Conrado Vogel(Instituto Nacional de Cancerología), Carlos Carracedo, Johanna Wittreich(Instituto Nacional de Cancerología), Jorge Martínez-Cedillo(Instituto Nacional de Cancerología), José Rodrigues Pereira, Alexandra D. Carides(Merck & Co., Inc., Rahway, NJ, USA (United States)), Lars-Olof Eriksson(Instituto Nacional de Cancerología), Rick R. Reinhardt(Instituto Nacional de Cancerología)
Journal of Clinical Oncology
March 15, 2001
Cited by 221


Related Papers